Products for Research Use Only
RegisterLogin

Salcaprozate-d4 (sodium)

CAT: 0804-HY-114299S-01Size: 500 µgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-114299S-01Size:500 µg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Salcaprozate-d4 (sodium) is a deuterated labeled Salcaprozate (sodium) [1]. Salcaprozate sodium (SNAC), an oral absorption promoter, and has the potential as a delivery agent for oral forms of heparin and insulin. Salcaprozate sodium could increase passive transcellular permeation across small intestinal epithelia based on increased lipophilicity arising from non-covalent macromolecule complexation[2][3].
Product Name Alternative
SNAC-d4 (sodium)
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Others
Field of Research
Others
Purity
99.72
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(O[Na])CCCCCCCNC(C1=C([2H])C([2H])=C([2H])C([2H])=C1O)=O
Molecular Formula
C15H16D4NNaO4
Molecular Weight
305.34
Precautions
H302, H315, H319, H335
References & Citations
[1]Riley MGI, et, al. Subchronic oral toxicity of salcaprozate sodium (SNAC) in Sprague-Dawley and Wistar rats. Int J Toxicol. Jul-Aug 2009; 28 (4) :278-93.|[2]Twarog C, et, al. Intestinal Permeation Enhancers for Oral Delivery of Macromolecules: A Comparison between Salcaprozate Sodium (SNAC) and Sodium Caprate (C 10) . Pharmaceutics. 2019 Feb 13; 11 (2) :78.|[3]Li Y, et, al. Impact of Sodium N-[8- (2-Hydroxybenzoyl) amino]-caprylate on Intestinal Permeability for Notoginsenoside R1 and Salvianolic Acids in Caco-2 Cells Transport and Rat Pharmacokinetics. Molecules. 2018 Nov 16; 23 (11) :2990.|[4]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-114299-01Salcaprozate (sodium)
HY-114299R-01Salcaprozate (sodium) (Standard)
HY-B1888ASBromfenac-d4 (sodium)
HY-B0656AS-01Rabeprazole-d4 (sodium)
HY-15037S1-01Diclofenac-d4 (sodium)
HY-108685SAlendronate-d4 (sodium)
HY-19696ASTauroursodeoxycholate-d4 (sodium)
HY-150523S-01Sodium borodeuteride-d4
HY-B0144BS-01Pitavastatin-d4 (sodium)
HY-113293BS1-01Estrone sulfate-d4 (sodium)

Alternative Products

CatalogName
CS-SN-00078Salcaprozate-d4 Sodium
TRC-S085600-50MGSalcaprozate Sodium
RM-S261713-01Salcaprozate Sodium Impurity 13
RM-S261730-01Salcaprozate Sodium Impurity 30
RG-A261709-01Salcaprozate sodium Impurity 17
RM-S261729-01Salcaprozate Sodium Impurity 29
RM-S261727-01Salcaprozate Sodium Impurity 27
RM-S261718-01Salcaprozate Sodium Impurity 18
RM-S261712-01Salcaprozate Sodium Impurity 12
RG-A262795-01Salcaprozate Sodium Impurity 16

Popular Products